Delic Survey Shows Americans With Mental Health Conditions Are Ready For Access To Psychedelics Jan 20, 2022
Revitalist Provides Summary of 2021, Reporting Patient Visits of 5,000, a 128% Increase From 2020 Jan 20, 2022
Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial Jan 19, 2022
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Jan 19, 2022
